Requires DOH to evaluate hospital compliance with federal hospital price transparency requirements.
Summary
This bill requires the New Jersey Department of Health to monitor and evaluate whether every licensed hospital in the state complies with the federal hospital price transparency rules in 45 C.F.R. Part 180. The department would be authorized to review complaints, outside analyses of noncompliance, and hospital websites to assess whether hospitals are posting required pricing information, including standard charges, in the form and manner required by federal law.
If the department finds a hospital out of compliance, it may issue a written warning, require a corrective action plan for a material violation, or impose a civil monetary penalty if the hospital fails to respond or correct the problem. The bill also requires annual public reporting to the Governor, Legislature, and the department’s website on hospital compliance and related findings or recommendations. It establishes notice, hearing, appeal, and publication procedures for penalties, and sets penalty amounts based on hospital size, with higher daily penalties for larger facilities.
Impact
The bill supplements Title 26 of the Revised Statutes by creating a state enforcement framework for federal hospital price transparency requirements. While the underlying transparency obligations come from federal regulation, the bill gives the Department of Health an explicit state role in monitoring compliance, determining whether violations are material, ordering corrective action plans, and imposing and publicizing civil monetary penalties. It would affect licensed hospitals subject to 45 C.F.R. Part 180 and could increase administrative oversight, reporting obligations, and financial exposure for noncompliant facilities.
Sentiment
The available context shows no recorded committee testimony or votes, so there is no documented legislative debate to gauge support or opposition. Based on the bill’s structure, it appears aimed at strengthening enforcement of existing transparency rules rather than creating new pricing disclosure standards, suggesting a consumer-protection and accountability focus. The absence of recorded opposition or amendments in the provided materials means sentiment cannot be assessed beyond the bill’s apparent policy intent.
Contention
The main potential point of contention is enforcement authority: the bill empowers the Department of Health to determine noncompliance, require corrective action plans, and impose daily civil monetary penalties, which hospitals may view as burdensome or duplicative of federal enforcement. Another likely issue is the public posting of penalty notices, which could be seen as increasing reputational pressure on hospitals. The bill also gives the department discretion to decide when a violation is “material” and to assess compliance through complaints and website audits, which could raise concerns about administrative discretion and due process, although the bill does provide notice and hearing rights.